European Retinoblastoma Group (EURbG) shared a post on LinkedIn:
“Once again, the 2025 ISGEDR meeting was an enriching experience. We are committed to continuing these valuable collaborations to improve our understanding of retinoblastoma and enhance treatment for our young patients.”
More from European Retinoblastoma Group on OncoDaily.